Travis Reber
Foot & Ankle Surgery · Flagstaff, AZNPI 1952436446
Payments from drug & device makers
Across 63 payments — averaging $36.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$857
- Orthofix Medical, Inc.$246
- Pfizer$241
- Impactortho, Inc.$233
- Arthrex$176
- AbbVie$123
- plus $414 from 15 others
What the payments were for
- Travel & lodging$85937%
- Food & beverage$1,43263%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 4 | $857 |
| Orthofix Medical, Inc. | 13 | $246 |
| Pfizer | 17 | $241 |
| Impactortho, Inc. | 1 | $233 |
| Arthrex | 3 | $176 |
| AbbVie | 6 | $123 |
| Amgen | 2 | $59 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| Averitas Pharma Inc. | 2 | $41 |
| Melinta Therapeutics, LLC | 1 | $34 |
| Biotissue Holdings Inc. | 1 | $33 |
| Medela LLC | 1 | $30 |
| Acell, Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| Merck | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $17 |
| DJO, LLC | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Bioventus LLC | 1 | $16 |
| Smith+Nephew | 1 | $13 |
How this compares
$2,292 in reported general payments places this provider in the 45th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 27 | $1,402 |
| Ciclopirox | 17 | $525 |
| Terbinafine Hcl | 24 | $523 |
| Ketoconazole | 36 | $459 |
| Allopurinol | 42 | $413 |
| Gabapentin | 28 | $197 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $137 |
| Methylprednisolone | 14 | $104 |
| Cephalexin | 11 | $87 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Flagstaff
- Christopher DiefenbachFlagstaff$69K
- Catlea GormanFlagstaff$17K
- Ryan ScottPhoenix$1.1M
- Jaminelli BanksPhoenix$974K
- Jeffrey McAlisterScottsdale$653K
- Jeffrey HolmesPhoenix$573K
- Myron HansenChandler$480K
- Scott MalingMesa$382K
- Melissa GalliPhoenix$331K
- Geoffrey LandisTucson$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.